{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:32:16Z","timestamp":1790937136495,"version":"4.1.0"},"publisher-location":"Cham","reference-count":159,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030685096","type":"print"},{"value":"9783030685102","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/164_2020_389","type":"book-chapter","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T12:03:16Z","timestamp":1597838596000},"page":"311-337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cardiovascular Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO\u2022) and Nitroxyl (HNO), in the Setting of Reactive Oxygen Species Dysregulation"],"prefix":"10.1007","author":[{"given":"Barbara K.","family":"Kemp-Harper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anida","family":"Velagic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazareno","family":"Paolocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca H.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"issue":"12","key":"389_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11892-019-1239-x","volume":"19","author":"R Almourani","year":"2019","unstructured":"Almourani R, Chinnakotla B, Patel R, Kurukulasuriya LR, Sowers J (2019) Diabetes and cardiovascular disease: an update. Curr Diab Rep 19(12):161","journal-title":"Curr Diab Rep"},{"issue":"1","key":"389_CR2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1515\/hsz-2019-0349","volume":"401","author":"MB Amdahl","year":"2019","unstructured":"Amdahl MB, DeMartino AW, Gladwin MT (2019) Inorganic nitrite bioactivation and role in physiological signaling and therapeutics. Biol Chem 401(1):201\u2013211","journal-title":"Biol Chem"},{"issue":"2","key":"389_CR3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3132\/dvdr.2005.015","volume":"2","author":"RA Anderson","year":"2005","unstructured":"Anderson RA, Ellis GR, Evans LM, Morris K, Chirkov YY, Horowitz JD, Jackson SK, Rees A, Lewis MJ, Frenneaux MP (2005) Platelet nitrate responsiveness in fasting and postprandial type 2 diabetes. Diab Vasc Dis Res 2(2):88\u201393","journal-title":"Diab Vasc Dis Res"},{"issue":"2","key":"389_CR4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/CS20140759","volume":"129","author":"KL Andrews","year":"2015","unstructured":"Andrews KL, Lumsden NG, Farry J, Jefferis AM, Kemp-Harper BK, Chin-Dusting JP (2015) Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance. Clin Sci (Lond) 129(2):179\u2013187","journal-title":"Clin Sci (Lond)"},{"issue":"18","key":"389_CR5","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1042\/CS20160097","volume":"130","author":"KL Andrews","year":"2016","unstructured":"Andrews KL, Sampson AK, Irvine JC, Shihata WA, Michell DL, Lumsden NG, Lim C, Huet O, Drummond GR, Kemp-Harper BK, Chin-Dusting JP (2016) Nitroxyl (HNO) reduces endothelial and monocyte activation and promotes M2 macrophage polarization. Clin Sci (Lond) 130(18):1629\u20131640","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"389_CR6","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2337\/db14-1011","volume":"64","author":"AS Antonopoulos","year":"2015","unstructured":"Antonopoulos AS, Margaritis M, Coutinho P, Shirodaria C, Psarros C, Herdman L, Sanna F, De Silva R, Petrou M, Sayeed R, Krasopoulos G, Lee R, Digby J, Reilly S, Bakogiannis C, Tousoulis D, Kessler B, Casadei B, Channon KM, Antoniades C (2015) Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: the regulatory role of perivascular adipose tissue. Diabetes 64(6):2207\u20132219","journal-title":"Diabetes"},{"issue":"3","key":"389_CR7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11897-014-0210-z","volume":"11","author":"A Arcaro","year":"2014","unstructured":"Arcaro A, Lembo G, Tocchetti CG (2014) Nitroxyl (HNO) for treatment of acute heart failure. Curr Heart Fail Rep 11(3):227\u2013235","journal-title":"Curr Heart Fail Rep"},{"issue":"1","key":"389_CR8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.CIR.62.1.160","volume":"62","author":"PW Armstrong","year":"1980","unstructured":"Armstrong PW, Armstrong JA, Marks GS (1980) Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure. Circulation 62(1):160\u2013166","journal-title":"Circulation"},{"issue":"11","key":"389_CR9","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/01.ATV.0000037101.40667.62","volume":"22","author":"H Azumi","year":"2002","unstructured":"Azumi H, Inoue N, Ohashi Y, Terashima M, Mori T, Fujita H, Awano K, Kobayashi K, Maeda K, Hata K, Shinke T, Kobayashi S, Hirata K, Kawashima S, Itabe H, Hayashi Y, Imajoh-Ohmi S, Itoh H, Yokoyama M (2002) Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase. Arterioscler Thromb Vasc Biol 22(11):1838\u20131844","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6878","key":"389_CR10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/416337a","volume":"416","author":"LA Barouch","year":"2002","unstructured":"Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE, Hare JM (2002) Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416(6878):337\u2013339","journal-title":"Nature"},{"issue":"5 Pt 1","key":"389_CR11","doi-asserted-by":"crossref","first-page":"C1424","DOI":"10.1152\/ajpcell.1996.271.5.C1424","volume":"271","author":"JS Beckman","year":"1996","unstructured":"Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Phys 271(5 Pt 1):C1424\u2013C1437","journal-title":"Am J Phys"},{"issue":"3","key":"389_CR12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1160\/TH05-01-0062","volume":"94","author":"E Bermejo","year":"2005","unstructured":"Bermejo E, Saenz DA, Alberto F, Rosenstein RE, Bari SE, Lazzari MA (2005) Effect of nitroxyl on human platelets function. Thromb Haemost 94(3):578\u2013584","journal-title":"Thromb Haemost"},{"issue":"5","key":"389_CR13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ahj.2012.08.014","volume":"164","author":"K Bishu","year":"2012","unstructured":"Bishu K, Deswal A, Chen HH, LeWinter MM, Lewis GD, Semigran MJ, Borlaug BA, McNulty S, Hernandez AF, Braunwald E, Redfield MM (2012) Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. Am Heart J 164(5):763\u2013770.e763","journal-title":"Am Heart J"},{"issue":"9","key":"389_CR14","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1089\/ars.2010.3327","volume":"14","author":"ML Bullen","year":"2011","unstructured":"Bullen ML, Miller AA, Andrews KL, Irvine JC, Ritchie RH, Sobey CG, Kemp-Harper BK (2011a) Nitroxyl (HNO) as a vasoprotective signaling molecule. Antioxid Redox Signal 14(9):1675\u20131686","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"389_CR15","doi-asserted-by":"crossref","first-page":"H1405","DOI":"10.1152\/ajpheart.00489.2011","volume":"301","author":"ML Bullen","year":"2011","unstructured":"Bullen ML, Miller AA, Dharmarajah J, Drummond GR, Sobey CG, Kemp-Harper BK (2011b) Vasorelaxant and antiaggregatory actions of the nitroxyl donor isopropylamine NONOate are maintained in hypercholesterolemia. Am J Physiol Heart Circ Physiol 301(4):H1405\u2013H1414","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"389_CR16","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1172\/JCI119883","volume":"101","author":"A Calderone","year":"1998","unstructured":"Calderone A, Thaik CM, Takahashi N, Chang DL, Colucci WS (1998) Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest 101(4):812\u2013818","journal-title":"J Clin Invest"},{"issue":"3","key":"389_CR17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCHEARTFAILURE.114.001699","volume":"8","author":"N Cao","year":"2015","unstructured":"Cao N, Wong YG, Rosli S, Kiriazis H, Huynh K, Qin C, Du XJ, Kemp-Harper BK, Ritchie RH (2015) Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo. Circ Heart Fail 8(3):572\u2013581","journal-title":"Circ Heart Fail"},{"issue":"4","key":"389_CR18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/01.CIR.74.4.815","volume":"74","author":"JD Carroll","year":"1986","unstructured":"Carroll JD, Lang RM, Neumann AL, Borow KM, Rajfer SI (1986) The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy. Circulation 74(4):815\u2013825","journal-title":"Circulation"},{"issue":"1","key":"389_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ceca.2004.07.001","volume":"37","author":"E Cheong","year":"2005","unstructured":"Cheong E, Tumbev V, Abramson J, Salama G, Stoyanovsky DA (2005) Nitroxyl triggers Ca2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors. Cell Calcium 37(1):87\u201396","journal-title":"Cell Calcium"},{"issue":"7","key":"389_CR20","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/bph.12568","volume":"171","author":"KY Chin","year":"2014","unstructured":"Chin KY, Qin C, Cao N, Kemp-Harper BK, Woodman OL, Ritchie RH (2014) The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms. Br J Pharmacol 171(7):1722\u20131734","journal-title":"Br J Pharmacol"},{"key":"389_CR21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.phrs.2015.12.006","volume":"104","author":"KY Chin","year":"2016","unstructured":"Chin KY, Michel L, Qin CX, Cao N, Woodman OL, Ritchie RH (2016) The HNO donor Angeli's salt offers potential haemodynamic advantages over NO or dobutamine in ischaemia-reperfusion injury in the rat heart ex vivo. Pharmacol Res 104:165\u2013175","journal-title":"Pharmacol Res"},{"issue":"2","key":"389_CR22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pharmthera.2007.06.012","volume":"116","author":"YY Chirkov","year":"2007","unstructured":"Chirkov YY, Horowitz JD (2007) Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier? Pharmacol Ther 116(2):287\u2013305","journal-title":"Pharmacol Ther"},{"issue":"9100","key":"389_CR23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)08417-1","volume":"351","author":"G Cotter","year":"1998","unstructured":"Cotter G, Metzkor E, Kaluski E, Faigenberg Z, Miller R, Simovitz A, Shaham O, Marghitay D, Koren M, Blatt A, Moshkovitz Y, Zaidenstein R, Golik A (1998) Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 351(9100):389\u2013393","journal-title":"Lancet"},{"issue":"5","key":"389_CR24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/jcph.1364","volume":"59","author":"D Cowart","year":"2019","unstructured":"Cowart D, Venuti RP, Lynch K, Guptill JT, Noveck RJ, Foo SY (2019) A phase 1 randomized study of single intravenous infusions of the novel nitroxyl donor BMS-986231 in healthy volunteers. J Clin Pharmacol 59(5):717\u2013730","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"389_CR25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/01.CIR.80.3.458","volume":"80","author":"DA Cox","year":"1989","unstructured":"Cox DA, Vita JA, Treasure CB, Fish RD, Alexander RW, Ganz P, Selwyn AP (1989) Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation 80(3):458\u2013465","journal-title":"Circulation"},{"key":"389_CR26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mam.2018.08.003","volume":"63","author":"F Cuello","year":"2018","unstructured":"Cuello F, Wittig I, Lorenz K, Eaton P (2018) Oxidation of cardiac myofilament proteins: priming for dysfunction? Mol Asp Med 63:47\u201358","journal-title":"Mol Asp Med"},{"issue":"Pt.3","key":"389_CR27","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1113\/jphysiol.2007.129254","volume":"580","author":"T Dai","year":"2007","unstructured":"Dai T, Tian Y, Tocchetti CG, Katori T, Murphy AM, Kass DA, Paolocci N, Gao WD (2007) Nitroxyl increases force development in rat cardiac muscle. J Physiol 580(Pt.3):951\u2013960","journal-title":"J Physiol"},{"issue":"11","key":"389_CR28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/ars.2015.6376","volume":"23","author":"A Daiber","year":"2015","unstructured":"Daiber A, Munzel T (2015) Organic nitrate therapy, nitrate tolerance, and nitrate-induced endothelial dysfunction: emphasis on redox biology and oxidative stress. Antioxid Redox Signal 23(11):899\u2013942","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"389_CR29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00392-007-0588-7","volume":"97","author":"A Daiber","year":"2008","unstructured":"Daiber A, Wenzel P, Oelze M, Munzel T (2008) New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance. Clin Res Cardiol 97(1):12\u201320","journal-title":"Clin Res Cardiol"},{"key":"389_CR30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.niox.2013.08.006","volume":"35","author":"RF Dautov","year":"2013","unstructured":"Dautov RF, Ngo DT, Licari G, Liu S, Sverdlov AL, Ritchie RH, Kemp-Harper BK, Horowitz JD, Chirkov YY (2013) The nitric oxide redox sibling nitroxyl partially circumvents impairment of platelet nitric oxide responsiveness. Nitric Oxide 35:72\u201378","journal-title":"Nitric Oxide"},{"issue":"2\u20133","key":"389_CR31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0014-2999(01)01289-4","volume":"430","author":"BJ De Witt","year":"2001","unstructured":"De Witt BJ, Marrone JR, Kaye AD, Keefer LK, Kadowitz PJ (2001) Comparison of responses to novel nitric oxide donors in the feline pulmonary vascular bed. Eur J Pharmacol 430(2\u20133):311\u2013315","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"389_CR32","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1039\/b310188f","volume":"128","author":"EA Demoncheaux","year":"2003","unstructured":"Demoncheaux EA, Foster PJ, Borland CD, Smith AP, Higenbottam TW, Davies MB (2003) Determination of trace concentrations of dissolved nitric oxide in a biological buffer. Analyst 128(10):1281\u20131285","journal-title":"Analyst"},{"issue":"3","key":"389_CR33","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1124\/jpet.111.185272","volume":"339","author":"W Ding","year":"2011","unstructured":"Ding W, Li Z, Shen X, Martin J, King SB, Sivakumaran V, Paolocci N, Gao WD (2011) Reversal of isoflurane-induced depression of myocardial contraction by nitroxyl via myofilament sensitization to Ca2+. J Pharmacol Exp Ther 339(3):825\u2013831","journal-title":"J Pharmacol Exp Ther"},{"key":"389_CR34","first-page":"406960","volume":"2014","author":"QN Dinh","year":"2014","unstructured":"Dinh QN, Drummond GR, Sobey CG, Chrissobolis S (2014) Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int 2014:406960","journal-title":"Biomed Res Int"},{"issue":"6","key":"389_CR35","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrd3403","volume":"10","author":"GR Drummond","year":"2011","unstructured":"Drummond GR, Selemidis S, Griendling KK, Sobey CG (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10(6):453\u2013471","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"389_CR36","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1089\/ars.2010.3838","volume":"14","author":"JF DuMond","year":"2011","unstructured":"DuMond JF, King SB (2011) The chemistry of nitroxyl-releasing compounds. Antioxid Redox Signal 14(9):1637\u20131648","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"389_CR37","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00004872-199008000-00012","volume":"8","author":"FG Dunn","year":"1990","unstructured":"Dunn FG, McLenachan J, Isles CG, Brown I, Dargie HJ, Lever AF, Lorimer AR, Murray GD, Pringle SD, Robertson JW (1990) Left ventricular hypertrophy and mortality in hypertension: an analysis of data from the Glasgow blood pressure clinic. J Hypertens 8(8):775\u2013782","journal-title":"J Hypertens"},{"issue":"2","key":"389_CR38","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbrc.2010.10.030","volume":"402","author":"A El-Armouche","year":"2010","unstructured":"El-Armouche A, Wahab A, Wittkopper K, Schulze T, Bottcher F, Pohlmann L, King SB, DuMond JF, Gerloff C, Boger RH, Eschenhagen T, Carrier L, Donzelli S (2010) The new HNO donor, 1-nitrosocyclohexyl acetate, increases contractile force in normal and beta-adrenergically desensitized ventricular myocytes. Biochem Biophys Res Commun 402(2):340\u2013344","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"389_CR39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/107424840400900403","volume":"9","author":"U Elkayam","year":"2004","unstructured":"Elkayam U, Bitar F, Akhter MW, Khan S, Patrus S, Derakhshani M (2004) Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations. J Cardiovasc Pharmacol Ther 9(4):227\u2013241","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"9","key":"389_CR40","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd2038","volume":"5","author":"OV Evgenov","year":"2006","unstructured":"Evgenov OV, Pacher P, Schmidt PM, Hasko G, Schmidt HH, Stasch JP (2006) NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 5(9):755\u2013768","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"389_CR41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrcardio.2017.224","volume":"15","author":"C Farah","year":"2018","unstructured":"Farah C, Michel LYM, Balligand JL (2018) Nitric oxide signalling in cardiovascular health and disease. Nat Rev Cardiol 15(5):292\u2013316","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"389_CR42","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cardiores.2006.11.018","volume":"73","author":"JL Favaloro","year":"2007","unstructured":"Favaloro JL, Kemp-Harper BK (2007) The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature. Cardiovasc Res 73(3):587\u2013596","journal-title":"Cardiovasc Res"},{"issue":"5","key":"389_CR43","doi-asserted-by":"crossref","first-page":"H1274","DOI":"10.1152\/ajpheart.00008.2009","volume":"296","author":"JL Favaloro","year":"2009","unstructured":"Favaloro JL, Kemp-Harper BK (2009) Redox variants of NO (NO{middle dot} and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms. Am J Physiol Heart Circ Physiol 296(5):H1274\u2013H1280","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"389_CR44","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1046\/j.1365-2125.2003.01946.x","volume":"56","author":"KE Fayers","year":"2003","unstructured":"Fayers KE, Cummings MH, Shaw KM, Laight DW (2003) Nitrate tolerance and the links with endothelial dysfunction and oxidative stress. Br J Clin Pharmacol 56(6):620\u2013628","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"389_CR45","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/ejhf.1504","volume":"21","author":"GM Felker","year":"2019","unstructured":"Felker GM, Borentain M, Cleland JG, DeSouza MM, Kessler PD, O'Connor CM, Seiffert D, Teerlink JR, Voors AA, McMurray JJV (2019) Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure. Eur J Heart Fail 21(8):1022\u20131031","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"389_CR46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0167-5273(94)90262-3","volume":"45","author":"M Ferratini","year":"1994","unstructured":"Ferratini M (1994) Risk of rebound phenomenon during nitrate withdrawal. Int J Cardiol 45(2):89\u201396","journal-title":"Int J Cardiol"},{"issue":"9328","key":"389_CR47","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","volume":"360","author":"F Follath","year":"2002","unstructured":"Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L, Steering C, S. Investigators of the Levosimendan Infusion versus Dobutamine (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360(9328):196\u2013202","journal-title":"Lancet"},{"issue":"50","key":"389_CR48","doi-asserted-by":"crossref","first-page":"13150","DOI":"10.1021\/bi801925p","volume":"47","author":"JP Froehlich","year":"2008","unstructured":"Froehlich JP, Mahaney JE, Keceli G, Pavlos CM, Goldstein R, Redwood AJ, Sumbilla C, Lee DI, Tocchetti CG, Kass DA, Paolocci N, Toscano JP (2008) Phospholamban thiols play a central role in activation of the cardiac muscle sarcoplasmic reticulum calcium pump by nitroxyl. Biochemistry 47(50):13150\u201313152","journal-title":"Biochemistry"},{"issue":"2","key":"389_CR49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/bph.14384","volume":"176","author":"JM Fukuto","year":"2019","unstructured":"Fukuto JM (2019) A recent history of nitroxyl chemistry, pharmacology and therapeutic potential. Br J Pharmacol 176(2):135\u2013146","journal-title":"Br J Pharmacol"},{"issue":"2","key":"389_CR50","first-page":"546","volume":"263","author":"JM Fukuto","year":"1992","unstructured":"Fukuto JM, Chiang K, Hszieh R, Wong P, Chaudhuri G (1992) The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and\/or endothelium-derived relaxing factor. J Pharmacol Exp Ther 263(2):546\u2013551","journal-title":"J Pharmacol Exp Ther"},{"key":"389_CR51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jinorgbio.2012.08.027","volume":"118","author":"JM Fukuto","year":"2013","unstructured":"Fukuto JM, Cisneros CJ, Kinkade RL (2013) A comparison of the chemistry associated with the biological signaling and actions of nitroxyl (HNO) and nitric oxide (NO). J Inorg Biochem 118:201\u2013208","journal-title":"J Inorg Biochem"},{"issue":"8","key":"389_CR52","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/CIRCRESAHA.112.270827","volume":"111","author":"WD Gao","year":"2012","unstructured":"Gao WD, Murray CI, Tian Y, Zhong X, DuMond JF, Shen X, Stanley BA, Foster DB, Wink DA, King SB, Van Eyk JE, Paolocci N (2012) Nitroxyl-mediated disulfide bond formation between cardiac myofilament cysteines enhances contractile function. Circ Res 111(8):1002\u20131011","journal-title":"Circ Res"},{"issue":"1","key":"389_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.fjc.0000189601.12276.8b","volume":"47","author":"AM Garreffa","year":"2006","unstructured":"Garreffa AM, Woodman OL, Cao AH, Ritchie RH (2006) Sodium nitroprusside protects adult rat cardiac myocytes from cellular injury induced by simulated ischemia: role for a non-cGMP-dependent mechanism of nitric oxide protection. J Cardiovasc Pharmacol 47(1):1\u20138","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"389_CR54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/ars.2007.9.101","volume":"9","author":"SS Goh","year":"2007","unstructured":"Goh SS, Woodman OL, Pepe S, Cao AH, Qin C, Ritchie RH (2007) The red wine antioxidant resveratrol prevents cardiomyocyte injury following ischemia-reperfusion via multiple sites and mechanisms. Antioxid Redox Signal 9(1):101\u2013113","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"389_CR55","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0735-1097(01)01510-8","volume":"38","author":"T Gori","year":"2001","unstructured":"Gori T, Mak SS, Kelly S, Parker JD (2001) Evidence supporting abnormalities in nitric oxide synthase function induced by nitroglycerin in humans. J Am Coll Cardiol 38(4):1096\u20131101","journal-title":"J Am Coll Cardiol"},{"issue":"6061","key":"389_CR56","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/320454a0","volume":"320","author":"RJ Gryglewski","year":"1986","unstructured":"Gryglewski RJ, Palmer RM, Moncada S (1986) Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320(6061):454\u2013456","journal-title":"Nature"},{"issue":"2","key":"389_CR57","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/01.ATV.0000196651.64776.51","volume":"26","author":"TJ Guzik","year":"2006","unstructured":"Guzik TJ, Sadowski J, Guzik B, Jopek A, Kapelak B, Przybylowski P, Wierzbicki K, Korbut R, Harrison DG, Channon KM (2006) Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol 26(2):333\u2013339","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"389_CR58","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1440-1681.2003.03873.x","volume":"30","author":"RD Hannan","year":"2003","unstructured":"Hannan RD, Jenkins A, Jenkins AK, Brandenburger Y (2003) Cardiac hypertrophy: a matter of translation. Clin Exp Pharmacol Physiol 30(8):517\u2013527","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"389_CR59","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jacbts.2018.07.003","volume":"3","author":"JC Hartman","year":"2018","unstructured":"Hartman JC, Del Rio CL, Reardon JE, Zhang K, Sabbah HN (2018) Intravenous infusion of the novel HNO donor BMS-986231 is associated with beneficial inotropic, lusitropic, and vasodilatory properties in 2 canine models of heart failure. JACC Basic Trans Sci 3(5):625\u2013638","journal-title":"JACC Basic Trans Sci"},{"issue":"11","key":"389_CR60","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s001250051551","volume":"43","author":"T Heitzer","year":"2000","unstructured":"Heitzer T, Krohn K, Albers S, Meinertz T (2000) Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus. Diabetologia 43(11):1435\u20131438","journal-title":"Diabetologia"},{"issue":"1","key":"389_CR61","first-page":"291","volume":"148","author":"MF Hill","year":"1996","unstructured":"Hill MF, Singal PK (1996) Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 148(1):291\u2013300","journal-title":"Am J Pathol"},{"issue":"4 Suppl A","key":"389_CR62","first-page":"6A","volume":"22","author":"KK Ho","year":"1993","unstructured":"Ho KK, Pinsky JL, Kannel WB, Levy D (1993) The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 22(4 Suppl A):6A\u201313A","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"389_CR63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/B:CARD.0000025923.41144.ec","volume":"18","author":"JD Horowitz","year":"2004","unstructured":"Horowitz JD (2004) Tolerance induction during therapy with long-acting nitrates: how extensive is the \"collateral damage\"? Cardiovasc Drugs Ther 18(1):11\u201312","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"389_CR64","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.pcad.2015.12.005","volume":"58","author":"R Hsiao","year":"2016","unstructured":"Hsiao R, Greenberg B (2016) Contemporary treatment of acute heart failure. Prog Cardiovasc Dis 58(4):367\u2013378","journal-title":"Prog Cardiovasc Dis"},{"key":"389_CR65","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0076-6879(99)01092-7","volume":"301","author":"MN Hughes","year":"1999","unstructured":"Hughes MN, Cammack R (1999) Synthesis, chemistry, and applications of nitroxyl ion releasers sodium trioxodinitrate or Angeli's salt and Piloty's acid. Methods Enzymol 301:279\u2013287","journal-title":"Methods Enzymol"},{"issue":"6","key":"389_CR66","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cmet.2008.03.010","volume":"7","author":"C Iadecola","year":"2008","unstructured":"Iadecola C, Davisson RL (2008) Hypertension and cerebrovascular dysfunction. Cell Metab 7(6):476\u2013484","journal-title":"Cell Metab"},{"issue":"3","key":"389_CR67","doi-asserted-by":"crossref","first-page":"H1070","DOI":"10.1152\/ajpheart.00940.2003","volume":"286","author":"F Ichinose","year":"2004","unstructured":"Ichinose F, Bloch KD, Wu JC, Hataishi R, Aretz HT, Picard MH, Scherrer-Crosbie M (2004) Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency. Am J Physiol Heart Circ Physiol 286(3):H1070\u2013H1075","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"389_CR68","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/01.HYP.0000072010.54901.DE","volume":"41","author":"JC Irvine","year":"2003","unstructured":"Irvine JC, Favaloro JL, Kemp-Harper BK (2003) NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries. Hypertension 41(6):1301\u20131307","journal-title":"Hypertension"},{"issue":"4","key":"389_CR69","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/01.HYP.0000259328.04159.90","volume":"49","author":"JC Irvine","year":"2007","unstructured":"Irvine JC, Favaloro JL, Widdop RE, Kemp-Harper BK (2007) Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae. Hypertension 49(4):885\u2013892","journal-title":"Hypertension"},{"issue":"12","key":"389_CR70","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.tips.2008.08.005","volume":"29","author":"JC Irvine","year":"2008","unstructured":"Irvine JC, Ritchie RH, Favaloro JL, Andrews KL, Widdop RE, Kemp-Harper BK (2008) Nitroxyl (HNO): the Cinderella of the nitric oxide story. Trends Pharmacol Sci 29(12):601\u2013608","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"389_CR71","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1089\/ars.2010.3269","volume":"14","author":"JC Irvine","year":"2011","unstructured":"Irvine JC, Kemp-Harper BK, Widdop RE (2011) Chronic administration of the HNO donor Angeli's salt does not lead to tolerance, cross-tolerance, or endothelial dysfunction: comparison with GTN and DEA\/NO. Antioxid Redox Signal 14(9):1615\u20131624","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"389_CR72","doi-asserted-by":"crossref","first-page":"H365","DOI":"10.1152\/ajpheart.00495.2012","volume":"305","author":"JC Irvine","year":"2013","unstructured":"Irvine JC, Cao N, Gossain S, Alexander AE, Love JE, Qin C, Horowitz JD, Kemp-Harper BK, Ritchie RH (2013a) HNO\/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO. Am J Physiol Heart Circ Physiol 305(3):H365\u2013H377","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"389_CR73","doi-asserted-by":"crossref","first-page":"H939","DOI":"10.1152\/ajpheart.00630.2012","volume":"305","author":"JC Irvine","year":"2013","unstructured":"Irvine JC, Ravi RM, Kemp-Harper BK, Widdop RE (2013b) Nitroxyl donors retain their depressor effects in hypertension. Am J Physiol Heart Circ Physiol 305(6):H939\u2013H945","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"389_CR74","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.phrs.2016.06.025","volume":"111","author":"N Kahlberg","year":"2016","unstructured":"Kahlberg N, Qin CX, Anthonisz J, Jap E, Ng HH, Jelinic M, Parry LJ, Kemp-Harper BK, Ritchie RH, Leo CH (2016) Adverse vascular remodelling is more sensitive than endothelial dysfunction to hyperglycaemia in diabetic rat mesenteric arteries. Pharmacol Res 111:325\u2013335","journal-title":"Pharmacol Res"},{"issue":"6","key":"389_CR75","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1085\/jgp.201812208","volume":"151","author":"G Keceli","year":"2019","unstructured":"Keceli G, Majumdar A, Thorpe CN, Jun S, Tocchetti CG, Lee DI, Mahaney JE, Paolocci N, Toscano JP (2019) Nitroxyl (HNO) targets phospholamban cysteines 41 and 46 to enhance cardiac function. J Gen Physiol 151(6):758\u2013770","journal-title":"J Gen Physiol"},{"issue":"14","key":"389_CR76","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s40265-016-0631-y","volume":"76","author":"BK Kemp-Harper","year":"2016","unstructured":"Kemp-Harper BK, Horowitz JD, Ritchie RH (2016) Therapeutic potential of nitroxyl (HNO) donors in the management of acute decompensated heart failure. Drugs 76(14):1337\u20131348","journal-title":"Drugs"},{"issue":"1 Pt 1","key":"389_CR77","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/01.HYP.35.1.43","volume":"35","author":"S Kloss","year":"2000","unstructured":"Kloss S, Bouloumie A, Mulsch A (2000) Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase. Hypertension 35(1 Pt 1):43\u201347","journal-title":"Hypertension"},{"key":"389_CR78","first-page":"614","volume":"2","author":"MJ Kohr","year":"2010","unstructured":"Kohr MJ, Kaludercic N, Tocchetti CG, Dong Gao W, Kass DA, Janssen PM, Paolocci N, Ziolo MT (2010) Nitroxyl enhances myocyte Ca2+ transients by exclusively targeting SR Ca2+-cycling. Front Biosci (Elite Ed) 2:614\u2013626","journal-title":"Front Biosci (Elite Ed)"},{"issue":"25","key":"389_CR79","doi-asserted-by":"crossref","first-page":"22546","DOI":"10.1074\/jbc.M302227200","volume":"278","author":"N Kuzkaya","year":"2003","unstructured":"Kuzkaya N, Weissmann N, Harrison DG, Dikalov S (2003) Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278(25):22546\u201322554","journal-title":"J Biol Chem"},{"issue":"6","key":"389_CR80","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCRESAHA.108.188441","volume":"104","author":"S Lancel","year":"2009","unstructured":"Lancel S, Zhang J, Evangelista A, Trucillo MP, Tong X, Siwik DA, Cohen RA, Colucci WS (2009) Nitroxyl activates SERCA in cardiac myocytes via glutathiolation of cysteine 674. Circ Res 104(6):720\u2013723","journal-title":"Circ Res"},{"issue":"6","key":"389_CR81","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1089\/ars.2007.1986","volume":"10","author":"MY Lee","year":"2008","unstructured":"Lee MY, Griendling KK (2008) Redox signaling, vascular function, and hypertension. Antioxid Redox Signal 10(6):1045\u20131059","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"389_CR82","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.phrs.2012.07.010","volume":"66","author":"CH Leo","year":"2012","unstructured":"Leo CH, Joshi A, Hart JL, Woodman OL (2012) Endothelium-dependent nitroxyl-mediated relaxation is resistant to superoxide anion scavenging and preserved in diabetic rat aorta. Pharmacol Res 66(5):383\u2013391","journal-title":"Pharmacol Res"},{"issue":"4","key":"389_CR84","volume":"7","author":"EQ Lin","year":"2012","unstructured":"Lin EQ, Irvine JC, Cao AH, Alexander AE, Love JE, Patel R, McMullen JR, Kaye DM, Kemp-Harper BK, Ritchie RH (2012) Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation. PLoS One 7(4):e34892","journal-title":"PLoS One"},{"issue":"25","key":"389_CR85","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1161\/CIRCULATIONAHA.107.741702","volume":"117","author":"X Loyer","year":"2008","unstructured":"Loyer X, Gomez AM, Milliez P, Fernandez-Velasco M, Vangheluwe P, Vinet L, Charue D, Vaudin E, Zhang W, Sainte-Marie Y, Robidel E, Marty I, Mayer B, Jaisser F, Mercadier JJ, Richard S, Shah AM, Benitah JP, Samuel JL, Heymes C (2008) Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling. Circulation 117(25):3187\u20133198","journal-title":"Circulation"},{"issue":"7","key":"389_CR86","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ejhf.294","volume":"17","author":"A Mebazaa","year":"2015","unstructured":"Mebazaa A, Longrois D, Metra M, Mueller C, Richards AM, Roessig L, Seronde MF, Sato N, Stockbridge NL, Gattis Stough W, Alonso A, Cody RJ, Cook Bruns N, Gheorghiade M, Holzmeister J, Laribi S, Zannad F (2015) Agents with vasodilator properties in acute heart failure: how to design successful trials. Eur J Heart Fail 17(7):652\u2013664","journal-title":"Eur J Heart Fail"},{"issue":"9587","key":"389_CR87","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(07)61299-9","volume":"370","author":"FH Messerli","year":"2007","unstructured":"Messerli FH, Williams B, Ritz E (2007) Essential hypertension. Lancet 370(9587):591\u2013603","journal-title":"Lancet"},{"issue":"33","key":"389_CR88","doi-asserted-by":"crossref","first-page":"21788","DOI":"10.1074\/jbc.M109.014282","volume":"284","author":"TW Miller","year":"2009","unstructured":"Miller TW, Cherney MM, Lee AJ, Francoleon NE, Farmer PJ, King SB, Hobbs AJ, Miranda KM, Burstyn JN, Fukuto JM (2009) The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols. J Biol Chem 284(33):21788\u201321796","journal-title":"J Biol Chem"},{"key":"389_CR89","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.freeradbiomed.2013.02.025","volume":"60","author":"AA Miller","year":"2013","unstructured":"Miller AA, Maxwell KF, Chrissobolis S, Bullen ML, Ku JM, Michael De Silva T, Selemidis S, Hooker EU, Drummond GR, Sobey CG, Kemp-Harper BK (2013) Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity. Free Radic Biol Med 60:264\u2013271","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"389_CR90","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0003-9861(02)00031-0","volume":"401","author":"KM Miranda","year":"2002","unstructured":"Miranda KM, Yamada K, Espey MG, Thomas DD, DeGraff W, Mitchell JB, Krishna MC, Colton CA, Wink DA (2002) Further evidence for distinct reactive intermediates from nitroxyl and peroxynitrite: effects of buffer composition on the chemistry of Angeli's salt and synthetic peroxynitrite. Arch Biochem Biophys 401(2):134\u2013144","journal-title":"Arch Biochem Biophys"},{"issue":"1\u20132","key":"389_CR91","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0162-0134(02)00498-1","volume":"93","author":"KM Miranda","year":"2003","unstructured":"Miranda KM, Nims RW, Thomas DD, Espey MG, Citrin D, Bartberger MD, Paolocci N, Fukuto JM, Feelisch M, Wink DA (2003) Comparison of the reactivity of nitric oxide and nitroxyl with heme proteins. A chemical discussion of the differential biological effects of these redox related products of NOS. J Inorg Biochem 93(1\u20132):52\u201360","journal-title":"J Inorg Biochem"},{"issue":"7","key":"389_CR92","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2174\/1568026054679290","volume":"5","author":"KM Miranda","year":"2005","unstructured":"Miranda KM, Nagasawa HT, Toscano JP (2005) Donors of HNO. Curr Top Med Chem 5(7):649\u2013664","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"389_CR93","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1046\/j.1365-2141.2001.02623.x","volume":"112","author":"TH Mondoro","year":"2001","unstructured":"Mondoro TH, Ryan BB, Hrinczenko BW, Schechter AN, Vostal JG, Alayash AI (2001) Biological action of nitric oxide donor compounds on platelets from patients with sickle cell disease. Br J Haematol 112(4):1048\u20131054","journal-title":"Br J Haematol"},{"issue":"8","key":"389_CR94","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/01.ATV.0000168896.64927.bb","volume":"25","author":"T Munzel","year":"2005","unstructured":"Munzel T, Daiber A, Ullrich V, Mulsch A (2005) Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol 25(8):1551\u20131557","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"34","key":"389_CR95","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1093\/eurheartj\/eht249","volume":"34","author":"T Munzel","year":"2013","unstructured":"Munzel T, Daiber A, Gori T (2013) More answers to the still unresolved question of nitrate tolerance. Eur Heart J 34(34):2666\u20132673","journal-title":"Eur Heart J"},{"issue":"3","key":"389_CR96","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.vph.2014.09.002","volume":"63","author":"T Munzel","year":"2014","unstructured":"Munzel T, Steven S, Daiber A (2014) Organic nitrates: update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction. Vasc Pharmacol 63(3):105\u2013113","journal-title":"Vasc Pharmacol"},{"issue":"6779","key":"389_CR97","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","volume":"404","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404(6779):787\u2013790","journal-title":"Nature"},{"issue":"8","key":"389_CR98","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.2337\/diabetes.54.8.2415","volume":"54","author":"EB Okon","year":"2005","unstructured":"Okon EB, Chung AW, Rauniyar P, Padilla E, Tejerina T, McManus BM, Luo H, van Breemen C (2005) Compromised arterial function in human type 2 diabetic patients. Diabetes 54(8):2415\u20132423","journal-title":"Diabetes"},{"issue":"1","key":"389_CR99","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0891-5849(02)01179-6","volume":"34","author":"P Pagliaro","year":"2003","unstructured":"Pagliaro P, Mancardi D, Rastaldo R, Penna C, Gattullo D, Miranda KM, Feelisch M, Wink DA, Kass DA, Paolocci N (2003) Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning. Free Radic Biol Med 34(1):33\u201343","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"389_CR100","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1006\/jmcc.2000.1334","volume":"33","author":"N Paolocci","year":"2001","unstructured":"Paolocci N, Biondi R, Bettini M, Lee CI, Berlowitz CO, Rossi R, Xia Y, Ambrosio G, L'Abbate A, Kass DA, Zweier JL (2001a) Oxygen radical-mediated reduction in basal and agonist-evoked NO release in isolated rat heart. J Mol Cell Cardiol 33(4):671\u2013679","journal-title":"J Mol Cell Cardiol"},{"issue":"18","key":"389_CR101","doi-asserted-by":"crossref","first-page":"10463","DOI":"10.1073\/pnas.181191198","volume":"98","author":"N Paolocci","year":"2001","unstructured":"Paolocci N, Saavedra WF, Miranda KM, Martignani C, Isoda T, Hare JM, Espey MG, Fukuto JM, Feelisch M, Wink DA, Kass DA (2001b) Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc Natl Acad Sci U S A 98(18):10463\u201310468","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"389_CR102","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1073\/pnas.0937302100","volume":"100","author":"N Paolocci","year":"2003","unstructured":"Paolocci N, Katori T, Champion HC, John MES, Miranda KM, Fukuto JM, Wink DA, Kass DA (2003) Positive inotropic and lusitropic effects of HNO\/NO- in failing hearts: independence from beta-adrenergic signaling. Proc Natl Acad Sci U S A 100(9):5537\u20135542","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"389_CR103","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.pharmthera.2006.11.002","volume":"113","author":"N Paolocci","year":"2007","unstructured":"Paolocci N, Jackson MI, Lopez BE, Miranda K, Tocchetti CG, Wink DA, Hobbs AJ, Fukuto JM (2007) The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO. Pharmacol Ther 113(2):442\u2013458","journal-title":"Pharmacol Ther"},{"issue":"10","key":"389_CR104","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/ejhf.793","volume":"19","author":"J Parissis","year":"2017","unstructured":"Parissis J, Bistola V, Ikonomidis I, Triposkiadis F (2017) Nitroxyl donors for acute heart failure: promising newcomers. Eur J Heart Fail 19(10):1333\u20131334","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"389_CR105","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.117.027575","volume":"136","author":"S Pasupathy","year":"2017","unstructured":"Pasupathy S, Tavella R, Grover S, Raman B, Procter NEK, Du YT, Mahadavan G, Stafford I, Heresztyn T, Holmes A, Zeitz C, Arstall M, Selvanayagam J, Horowitz JD, Beltrame JF (2017) Early use of N-acetylcysteine with nitrate therapy in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction reduces myocardial infarct size (the NACIAM trial [N-acetylcysteine in acute myocardial infarction]). Circulation 136(10):894\u2013903","journal-title":"Circulation"},{"issue":"1","key":"389_CR106","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1748-1716.2008.01862.x","volume":"194","author":"L Paulis","year":"2008","unstructured":"Paulis L, Matuskova J, Adamcova M, Pelouch V, Simko J, Krajcirovicova K, Potacova A, Hulin I, Janega P, Pechanova O, Simko F (2008) Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone. Acta Physiol (Oxf) 194(1):45\u201355","journal-title":"Acta Physiol (Oxf)"},{"issue":"5","key":"389_CR107","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1161\/01.CIR.89.5.2070","volume":"89","author":"WJ Paulus","year":"1994","unstructured":"Paulus WJ, Vantrimpont PJ, Shah AM (1994) Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 89(5):2070\u20132078","journal-title":"Circulation"},{"issue":"1","key":"389_CR108","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/08941930802709470","volume":"22","author":"L Phillips","year":"2009","unstructured":"Phillips L, Toledo AH, Lopez-Neblina F, Anaya-Prado R, Toledo-Pereyra LH (2009) Nitric oxide mechanism of protection in ischemia and reperfusion injury. J Investig Surg 22(1):46\u201355","journal-title":"J Investig Surg"},{"issue":"1","key":"389_CR109","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/bbrc.1994.1668","volume":"201","author":"RZ Pino","year":"1994","unstructured":"Pino RZ, Feelisch M (1994) Bioassay discrimination between nitric oxide (NO.) and nitroxyl (NO-) using L-cysteine. Biochem Biophys Res Commun 201(1):54\u201362","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"389_CR110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1089\/ars.2018.7706","volume":"32","author":"CX Qin","year":"2020","unstructured":"Qin CX, Anthonisz J, Leo CH, Kahlberg N, Velagic A, Li M, Jap E, Woodman OL, Parry LJ, Horowitz JD, Kemp-Harper BK, Ritchie RH (2020) Nitric oxide resistance, induced in the myocardium by diabetes, is circumvented by the nitric oxide redox sibling, nitroxyl. Antioxid Redox Signal 32(1):60\u201377","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"389_CR111","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0002-9149(99)00025-9","volume":"83","author":"R Rajaratnam","year":"1999","unstructured":"Rajaratnam R, Brieger DB, Hawkins R, Freedman SB (1999) Attenuation of anti-ischemic efficacy during chronic therapy with nicorandil in patients with stable angina pectoris. Am J Cardiol 83(7):1120\u20131124, A1129","journal-title":"Am J Cardiol"},{"issue":"11","key":"389_CR112","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","volume":"126","author":"RH Ritchie","year":"2020","unstructured":"Ritchie RH, Abel ED (2020) Basic mechanisms of diabetic heart disease. Circ Res 126(11):1501\u20131525","journal-title":"Circ Res"},{"issue":"4 Pt 2","key":"389_CR113","first-page":"H1370","volume":"275","author":"RH Ritchie","year":"1998","unstructured":"Ritchie RH, Schiebinger RJ, LaPointe MC, Marsh JD (1998) Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide. Am J Phys 275(4 Pt 2):H1370\u2013H1374","journal-title":"Am J Phys"},{"issue":"3","key":"389_CR114","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pharmthera.2009.08.001","volume":"124","author":"RH Ritchie","year":"2009","unstructured":"Ritchie RH, Irvine JC, Rosenkranz AC, Patel R, Wendt IR, Horowitz JD, Kemp-Harper BK (2009) Exploiting cGMP-based therapies for the prevention of left ventricular hypertrophy: NO* and beyond. Pharmacol Ther 124(3):279\u2013300","journal-title":"Pharmacol Ther"},{"key":"389_CR115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.phrs.2016.12.017","volume":"116","author":"RH Ritchie","year":"2017","unstructured":"Ritchie RH, Drummond GR, Sobey CG, De Silva TM, Kemp-Harper BK (2017) The opposing roles of NO and oxidative stress in cardiovascular disease. Pharmacol Res 116:57\u201369","journal-title":"Pharmacol Res"},{"key":"389_CR116","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3389\/fphys.2017.00894","volume":"8","author":"SR Roof","year":"2017","unstructured":"Roof SR, Ueyama Y, Mazhari R, Hamlin RL, Hartman JC, Ziolo MT, Reardon JE, Del Rio CL (2017) CXL-1020, a novel nitroxyl (HNO) prodrug, is more effective than milrinone in models of diastolic dysfunction-A cardiovascular therapeutic: an efficacy and safety study in the rat. Front Physiol 8:894","journal-title":"Front Physiol"},{"issue":"4","key":"389_CR117","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/01.HYP.0000032854.74042.CF","volume":"40","author":"AC Rosenkranz","year":"2002","unstructured":"Rosenkranz AC, Hood SG, Woods RL, Dusting GJ, Ritchie RH (2002) Acute antihypertrophic actions of bradykinin in the rat heart: importance of cyclic GMP. Hypertension 40(4):498\u2013503","journal-title":"Hypertension"},{"issue":"3","key":"389_CR118","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jacc.2008.08.064","volume":"53","author":"A Rudolph","year":"2009","unstructured":"Rudolph A, Abdel-Aty H, Bohl S, Boye P, Zagrosek A, Dietz R, Schulz-Menger J (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 53(3):284\u2013291","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"389_CR119","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.RES.85.6.534","volume":"85","author":"H Ruetten","year":"1999","unstructured":"Ruetten H, Zabel U, Linz W, Schmidt HH (1999) Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ Res 85(6):534\u2013541","journal-title":"Circ Res"},{"issue":"6","key":"389_CR120","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/CIRCHEARTFAILURE.113.000632","volume":"6","author":"HN Sabbah","year":"2013","unstructured":"Sabbah HN, Tocchetti CG, Wang M, Daya S, Gupta RC, Tunin RS, Mazhari R, Takimoto E, Paolocci N, Cowart D, Colucci WS, Kass DA (2013) Nitroxyl (HNO): a novel approach for the acute treatment of heart failure. Circ Heart Fail 6(6):1250\u20131258","journal-title":"Circ Heart Fail"},{"issue":"23","key":"389_CR121","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1161\/01.CIR.102.23.2810","volume":"102","author":"PR Sage","year":"2000","unstructured":"Sage PR, de la Lande IS, Stafford I, Bennett CL, Phillipov G, Stubberfield J, Horowitz JD (2000) Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion. Circulation 102(23):2810\u20132815","journal-title":"Circulation"},{"issue":"16","key":"389_CR122","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/01.CIR.101.16.1899","volume":"101","author":"V Schachinger","year":"2000","unstructured":"Schachinger V, Britten MB, Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101(16):1899\u20131906","journal-title":"Circulation"},{"issue":"6","key":"389_CR123","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/hr.2011.39","volume":"34","author":"E Schulz","year":"2011","unstructured":"Schulz E, Gori T, Munzel T (2011) Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res 34(6):665\u2013673","journal-title":"Hypertens Res"},{"issue":"29","key":"389_CR124","doi-asserted-by":"crossref","first-page":"30369","DOI":"10.1074\/jbc.M400549200","volume":"279","author":"PC Schulze","year":"2004","unstructured":"Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, Lee RT (2004) Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 279(29):30369\u201330374","journal-title":"J Biol Chem"},{"issue":"2","key":"389_CR125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cardiores.2007.03.030","volume":"75","author":"S Selemidis","year":"2007","unstructured":"Selemidis S, Dusting GJ, Peshavariya H, Kemp-Harper BK, Drummond GR (2007) Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells. Cardiovasc Res 75(2):349\u2013358","journal-title":"Cardiovasc Res"},{"issue":"3","key":"389_CR126","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pharmthera.2008.08.005","volume":"120","author":"S Selemidis","year":"2008","unstructured":"Selemidis S, Sobey CG, Wingler K, Schmidt HH, Drummond GR (2008) NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther 120(3):254\u2013291","journal-title":"Pharmacol Ther"},{"issue":"30","key":"389_CR127","doi-asserted-by":"crossref","first-page":"9687","DOI":"10.1021\/ja062365a","volume":"128","author":"X Sha","year":"2006","unstructured":"Sha X, Isbell TS, Patel RP, Day CS, King SB (2006) Hydrolysis of acyloxy nitroso compounds yields nitroxyl (HNO). J Am Chem Soc 128(30):9687\u20139692","journal-title":"J Am Chem Soc"},{"issue":"25","key":"389_CR128","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1161\/CIRCULATIONAHA.112.140335","volume":"126","author":"A Shemyakin","year":"2012","unstructured":"Shemyakin A, Kovamees O, Rafnsson A, Bohm F, Svenarud P, Settergren M, Jung C, Pernow J (2012) Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus. Circulation 126(25):2943\u20132950","journal-title":"Circulation"},{"issue":"4","key":"389_CR129","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1021\/jm101432z","volume":"54","author":"ME Shoman","year":"2011","unstructured":"Shoman ME, DuMond JF, Isbell TS, Crawford JH, Brandon A, Honovar J, Vitturi DA, White CR, Patel RP, King SB (2011) Acyloxy nitroso compounds as nitroxyl (HNO) donors: kinetics, reactions with thiols, and vasodilation properties. J Med Chem 54(4):1059\u20131070","journal-title":"J Med Chem"},{"key":"389_CR130","first-page":"269","volume":"6","author":"MA Silva","year":"2015","unstructured":"Silva MA, Bruder-Nascimento T, Cau SB, Lopes RA, Mestriner FL, Fais RS, Touyz RM, Tostes RC (2015) Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO\/GC signaling. Front Physiol 6:269","journal-title":"Front Physiol"},{"issue":"11","key":"389_CR131","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1089\/ars.2012.5057","volume":"19","author":"V Sivakumaran","year":"2013","unstructured":"Sivakumaran V, Stanley BA, Tocchetti CG, Ballin JD, Caceres V, Zhou L, Keceli G, Rainer PP, Lee DI, Huke S, Ziolo MT, Kranias EG, Toscano JP, Wilson GM, O'Rourke B, Kass DA, Mahaney JE, Paolocci N (2013) HNO enhances SERCA2a activity and cardiomyocyte function by promoting redox-dependent phospholamban oligomerization. Antioxid Redox Signal 19(11):1185\u20131197","journal-title":"Antioxid Redox Signal"},{"issue":"9","key":"389_CR132","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI28371","volume":"116","author":"JP Stasch","year":"2006","unstructured":"Stasch JP, Schmidt PM, Nedvetsky PI, Nedvetskaya TY, Arun Kumar HS, Meurer S, Deile M, Taye A, Knorr A, Lapp H, Muller H, Turgay Y, Rothkegel C, Tersteegen A, Kemp-Harper B, Muller-Esterl W, Schmidt HH (2006) Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. J Clin Invest 116(9):2552\u20132561","journal-title":"J Clin Invest"},{"key":"389_CR133","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.freeradbiomed.2012.09.005","volume":"54","author":"J Sun","year":"2013","unstructured":"Sun J, Aponte AM, Kohr MJ, Tong G, Steenbergen C, Murphy E (2013) Essential role of nitric oxide in acute ischemic preconditioning: S-nitros(yl)ation versus sGC\/cGMP\/PKG signaling? Free Radic Biol Med 54:105\u2013112","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"389_CR134","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.niox.2011.04.009","volume":"25","author":"AL Sverdlov","year":"2011","unstructured":"Sverdlov AL, Ngo DT, Nightingale AK, Rajendran S, Mishra K, Heresztyn T, Ritchie RH, Marwick TH, Frenneaux MP, Horowitz JD (2011) The endogenous NOS inhibitor asymmetric dimethylarginine (ADMA) predicts LV mass independent of afterload. Nitric Oxide 25(1):41\u201346","journal-title":"Nitric Oxide"},{"key":"389_CR135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00210-016-1336-1","volume":"390","author":"M Tare","year":"2017","unstructured":"Tare M, Kalidindi RS, Bubb KJ, Parkington HC, Boon WM, Li X, Sobey CG, Drummond GR, Ritchie RH, Kemp-Harper BK (2017) Vasoactive actions of nitroxyl (HNO) are preserved in resistance arteries in diabetes. Naunyn Schmiedeberg's Arch Pharmacol 390:397\u2013408","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"issue":"20","key":"389_CR136","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","volume":"351","author":"AL Taylor","year":"2004","unstructured":"Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R Jr, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN, I. African-American Heart Failure Trial (2004) Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351(20):2049\u20132057","journal-title":"N Engl J Med"},{"issue":"10","key":"389_CR137","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1089\/ars.2008.2027","volume":"10","author":"SR Thomas","year":"2008","unstructured":"Thomas SR, Witting PK, Drummond GR (2008) Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 10(10):1713\u20131765","journal-title":"Antioxid Redox Signal"},{"issue":"10","key":"389_CR138","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/ejhf.897","volume":"19","author":"C Tita","year":"2017","unstructured":"Tita C, Gilbert EM, Van Bakel AB, Grzybowski J, Haas GJ, Jarrah M, Dunlap SH, Gottlieb SS, Klapholz M, Patel PC, Pfister R, Seidler T, Shah KB, Zielinski T, Venuti RP, Cowart D, Foo SY, Vishnevsky A, Mitrovic V (2017) A phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction. Eur J Heart Fail 19(10):1321\u20131332","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"389_CR139","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.RES.0000253904.53601.c9","volume":"100","author":"CG Tocchetti","year":"2007","unstructured":"Tocchetti CG, Wang W, Froehlich JP, Huke S, Aon MA, Wilson GM, Di Benedetto G, O'Rourke B, Gao WD, Wink DA, Toscano JP, Zaccolo M, Bers DM, Valdivia HH, Cheng H, Kass DA, Paolocci N (2007) Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling. Circ Res 100(1):96\u2013104","journal-title":"Circ Res"},{"issue":"3","key":"389_CR140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pharmthera.2014.06.003","volume":"144","author":"D Tousoulis","year":"2014","unstructured":"Tousoulis D, Simopoulou C, Papageorgiou N, Oikonomou E, Hatzis G, Siasos G, Tsiamis E, Stefanadis C (2014) Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches. Pharmacol Ther 144(3):253\u2013267","journal-title":"Pharmacol Ther"},{"issue":"3","key":"389_CR141","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.HYP.0000138070.47616.9d","volume":"44","author":"RM Touyz","year":"2004","unstructured":"Touyz RM (2004) Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44(3):248\u2013252","journal-title":"Hypertension"},{"issue":"5","key":"389_CR142","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jvs.2009.12.028","volume":"51","author":"ND Tsihlis","year":"2010","unstructured":"Tsihlis ND, Murar J, Kapadia MR, Ahanchi SS, Oustwani CS, Saavedra JE, Keefer LK, Kibbe MR (2010) Isopropylamine NONOate (IPA\/NO) moderates neointimal hyperplasia following vascular injury. J Vasc Surg 51(5):1248\u20131259","journal-title":"J Vasc Surg"},{"key":"389_CR143","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biopha.2017.03.043","volume":"90","author":"F Tullio","year":"2017","unstructured":"Tullio F, Penna C, Cabiale K, Femmino S, Galloni M, Pagliaro P (2017) Cardioprotective effects of calcitonin gene-related peptide in isolated rat heart and in H9c2 cells via redox signaling. Biomed Pharmacother 90:194\u2013202","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"389_CR144","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00125-002-0862-1","volume":"45","author":"RW van Etten","year":"2002","unstructured":"van Etten RW, de Koning EJ, Verhaar MC, Gaillard CA, Rabelink TJ (2002) Impaired NO-dependent vasodilation in patients with type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia 45(7):1004\u20131010","journal-title":"Diabetologia"},{"key":"389_CR145","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3389\/fphar.2020.00727","volume":"11","author":"A Velagic","year":"2020","unstructured":"Velagic A, Qin C, Woodman OL, Horowitz JD, Ritchie RH, Kemp-Harper BK (2020) Nitroxyl: a novel strategy to circumvent diabetes associated impairments in nitric oxide signaling. Front Pharmacol 11:727","journal-title":"Front Pharmacol"},{"issue":"3","key":"389_CR146","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0735-1097(95)00522-6","volume":"27","author":"SB Williams","year":"1996","unstructured":"Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA (1996) Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 27(3):567\u2013574","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"389_CR147","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1053\/euhj.2002.3296","volume":"23","author":"SR Willoughby","year":"2002","unstructured":"Willoughby SR, Stewart S, Chirkov YY, Kennedy JA, Holmes AS, Horowitz JD (2002) Beneficial clinical effects of perhexiline in patients with stable angina pectoris and acute coronary syndromes are associated with potentiation of platelet responsiveness to nitric oxide. Eur Heart J 23(24):1946\u20131954","journal-title":"Eur Heart J"},{"issue":"10","key":"389_CR148","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jacc.2012.01.066","volume":"60","author":"SR Willoughby","year":"2012","unstructured":"Willoughby SR, Rajendran S, Chan WP, Procter N, Leslie S, Liberts EA, Heresztyn T, Chirkov YY, Horowitz JD (2012) Ramipril sensitizes platelets to nitric oxide: implications for therapy in high-risk patients. J Am Coll Cardiol 60(10):887\u2013894","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"389_CR149","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/HYPERTENSIONAHA.109.149187","volume":"56","author":"S Wind","year":"2010","unstructured":"Wind S, Beuerlein K, Armitage ME, Taye A, Kumar AH, Janowitz D, Neff C, Shah AM, Wingler K, Schmidt HH (2010) Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1\/2 is reversed by NADPH oxidase inhibition. Hypertension 56(3):490\u2013497","journal-title":"Hypertension"},{"issue":"11","key":"389_CR150","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0891-5849(01)00727-4","volume":"31","author":"K Wingler","year":"2001","unstructured":"Wingler K, Wunsch S, Kreutz R, Rothermund L, Paul M, Schmidt HH (2001) Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med 31(11):1456\u20131464","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"389_CR151","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/abbi.1997.0565","volume":"351","author":"DA Wink","year":"1998","unstructured":"Wink DA, Feelisch M, Fukuto J, Chistodoulou D, Jourd'heuil D, Grisham MB, Vodovotz Y, Cook JA, Krishna M, DeGraff WG, Kim S, Gamson J, Mitchell JB (1998) The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO. Arch Biochem Biophys 351(1):66\u201374","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"389_CR152","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1023\/A:1020706316429","volume":"7","author":"KC Wollert","year":"2002","unstructured":"Wollert KC, Drexler H (2002) Regulation of cardiac remodeling by nitric oxide: focus on cardiac myocyte hypertrophy and apoptosis. Heart Fail Rev 7(4):317\u2013325","journal-title":"Heart Fail Rev"},{"issue":"3","key":"389_CR153","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacc.2006.08.053","volume":"49","author":"MI Worthley","year":"2007","unstructured":"Worthley MI, Holmes AS, Willoughby SR, Kucia AM, Heresztyn T, Stewart S, Chirkov YY, Zeitz CJ, Horowitz JD (2007) The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration. J Am Coll Cardiol 49(3):304\u2013310","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"389_CR154","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.phrs.2011.07.002","volume":"65","author":"BM Wynne","year":"2012","unstructured":"Wynne BM, Labazi H, Tostes RC, Webb RC (2012) Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses. Pharmacol Res 65(1):41\u201347","journal-title":"Pharmacol Res"},{"issue":"8","key":"389_CR155","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.106.684795","volume":"116","author":"J Xu","year":"2007","unstructured":"Xu J, Wu Y, Song P, Zhang M, Wang S, Zou MH (2007) Proteasome-dependent degradation of guanosine 5\u2032-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation 116(8):944\u2013953","journal-title":"Circulation"},{"issue":"3","key":"389_CR156","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/cvr\/cvq248","volume":"88","author":"QC Yong","year":"2010","unstructured":"Yong QC, Hu LF, Wang S, Huang D, Bian JS (2010) Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl. Cardiovasc Res 88(3):482\u2013491","journal-title":"Cardiovasc Res"},{"issue":"5","key":"389_CR157","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.HYP.35.5.1055","volume":"35","author":"G Zalba","year":"2000","unstructured":"Zalba G, Beaumont FJ, San Jose G, Fortuno A, Fortuno MA, Etayo JC, Diez J (2000) Vascular NADH\/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35(5):1055\u20131061","journal-title":"Hypertension"},{"issue":"Pt 2","key":"389_CR158","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1042\/bj3120333","volume":"312","author":"R Zamora","year":"1995","unstructured":"Zamora R, Grzesiok A, Weber H, Feelisch M (1995) Oxidative release of nitric oxide accounts for guanylyl cyclase stimulating, vasodilator and anti-platelet activity of Piloty's acid: a comparison with Angeli's salt. Biochem J 312(Pt 2):333\u2013339","journal-title":"Biochem J"},{"issue":"5","key":"389_CR159","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1124\/mol.109.059915","volume":"76","author":"A Zeller","year":"2009","unstructured":"Zeller A, Wenzl MV, Beretta M, Stessel H, Russwurm M, Koesling D, Schmidt K, Mayer B (2009) Mechanisms underlying activation of soluble guanylate cyclase by the nitroxyl donor Angeli's salt. Mol Pharmacol 76(5):1115\u20131122","journal-title":"Mol Pharmacol"},{"issue":"2","key":"389_CR160","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/HYPERTENSIONAHA.114.04285","volume":"65","author":"G Zhu","year":"2015","unstructured":"Zhu G, Groneberg D, Sikka G, Hori D, Ranek MJ, Nakamura T, Takimoto E, Paolocci N, Berkowitz DE, Friebe A, Kass DA (2015) Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse. Hypertension 65(2):385\u2013392","journal-title":"Hypertension"}],"container-title":["Handbook of Experimental Pharmacology","Reactive Oxygen Species"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2020_389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T13:30:00Z","timestamp":1614087000000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2020_389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030685096","9783030685102"],"references-count":159,"URL":"https:\/\/doi.org\/10.1007\/164_2020_389","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"20 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}